New perspectives for children with cancer

In addition to participating in clinical trials conducted by pharmaceutical companies and other hospitals (conducted in the Clinical Trial Unit), KiTZ also develops and leads its own experimental clinical phase I/II trials. The Trial Development Group uses current research findings to develop new innovative treatment concepts. The Study Management Group is responsible for planning, coordinating, and administration of translational studies.

Trial Development Group

Cornelis van Tilburg, MD, PhD

Study Management Group

Ruth Witt

All KiTZ publications at a glance.